Quality & complianceOfficial

Class II drug recall: Exenatide Injection (Amneal Pharmaceuticals Of New York, Llc)

🇺🇸 FDA enforcement report · Wed 30 Sep 2026

Defective Delivery System: Possibility of no medication in the prefilled pen. Recall D-0868-2026; status Ongoing; distribution: USA Nationwide.

Official source: FDA enforcement report ↗

Brief written by VigiEye from the company's press release. Claims are the company's own. AI-assisted; check the source before acting.

More Quality & compliance All →